BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers. 2014

Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India; Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500 037, India. Electronic address: ahmedkamal@iict.res.in.

A series of 1,2,3-triazole linked aminocombretastatin conjugates were synthesized and evaluated for cytotoxicity, inhibition of tubulin polymerization and apoptosis inducing ability. Most of the conjugates exhibited significant anticancer activity against some representative human cancer cell lines and two of the conjugates 6d and 7c displayed potent cytotoxicity with IC50 values of 53 nM and 44 nM against A549 human lung cancer respectively, and were comparable to combretastatin A-4 (CA-4). SAR studies revealed that 1-benzyl substituted triazole moiety with an amide linkage at 3-position of B-ring of the combretastatin subunit are more active compared to 2-position. G2/M cell cycle arrest was induced by these conjugates 6d and 7c and the tubulin polymerization assay (IC50 of 1.16 μM and 0.95 μM for 6d and 7c, respectively) as well as immunofluorescence analysis showed that these conjugates effectively inhibit microtubule assembly at both molecular and cellular levels in A549 cells. Colchicine competitive binding assay suggested that these conjugates bind at the colchicine binding site of tubulin as also observed from the docking studies. Further, mitochondrial membrane potential, ROS generation, caspase-3 activation assay, Hoechst staining and DNA fragmentation analysis revealed that these conjugates induce cell death by apoptosis.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001632 Bibenzyls Compounds that include 1,2-diphenylethane in their structure. Bisbenzyls
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Synthesis and biological evaluation of benzimidazole-linked 1,2,3-triazole congeners as agents.
December 2014, Organic and medicinal chemistry letters,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
November 2016, European journal of medicinal chemistry,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.
October 2021, RSC medicinal chemistry,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors.
June 2009, European journal of organic chemistry,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
October 2018, Bioorganic chemistry,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Design, Modeling and Synthesis of 1,2,3-Triazole-Linked Nucleoside-Amino Acid Conjugates as Potential Antibacterial Agents.
October 2017, Molecules (Basel, Switzerland),
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Synthesis, biological evaluation and molecular modeling studies of novel 1,2,3-triazole-linked menadione-furan derivatives as P2X7 inhibitors.
December 2022, Journal of bioenergetics and biomembranes,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Design, synthesis and immunological evaluation of 1,2,3-triazole-tethered carbohydrate-Pam3Cys conjugates as TLR2 agonists.
September 2015, Bioorganic & medicinal chemistry,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation.
July 2017, European journal of medicinal chemistry,
Ahmed Kamal, and Bajee Shaik, and V Lakshma Nayak, and Burri Nagaraju, and Jeevak Sopanrao Kapure, and M Shaheer Malik, and Thokhir Basha Shaik, and B Prasad
Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
August 2017, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!